UPClytics
EnglishDeutsch
Sign inSign up
View All PartiesView in Analytics

Regeneron Pharmaceuticals Inc.

Follow
Total cases
9 (1 active)
Claimant-side
4
Respondent-side
5

Regeneron Pharmaceuticals Inc. has been party to nine Unified Patent Court cases, 4 times as claimant and 5 times as respondent. The most recent on record is UPC CFI 2221/2025 at the Munich Central Division, brought by Amgen Inc.

Adversary analytics require an account

Sign in to see top opponents and the firms representing each side.

Sign in or create an account
Recent cases
View all cases
  • 2025-12-23UPC CFI 2221/2025—Amgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2025-07-11UPC CoA 646/2025WithdrawnAmgen NV v Regeneron Pharmaceuticals Inc.
  • 2025-02-28UPC CFI 195/2025WithdrawnSanofi Biotechnology SAS v Amgen Inc.
  • 2024-09-13UPC CoA 529/2024Patent upheld as grantedAmgen Inc. v Regeneron Pharmaceuticals Inc.
  • 2024-05-03CC 24999/2024Patent upheld as grantedAmgen S.R.L. v Regeneron Pharmaceuticals Inc.
  • 2023-11-10CC 586764/2023Patent revokedRegeneron Pharmaceuticals Inc. v Amgen Inc.
  • 2023-09-13UPC CoA 320/2023Procedural onlySanofi-Aventis Deutschland GmbH v Amgen Inc.
  • 2023-06-26UPC CFI 14/2023Procedural onlyAmgen Inc. v Sanofi-Aventis Deutschland GmbH
  • —ACT 597355/2023No infringementSanofi Biotechnology SAS v Amgen Inc.